AQUESTIVE THERAPEUTICS INC (AQST)
US03843E1047 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -28.77M | -7.87M | -54.41M | -70.54M | -55.78M | |||
| Depreciation Amortization | 1.22M | 1.34M | 2.39M | 2.96M | 3.44M | |||
| Change In Working Capital | -7.67M | -5.34M | 32.01M | -1.73M | -4.41M | |||
| Interest Paid | 4.13M | 4.60M | 6.44M | 6.44M | 8.49M | |||
| Other non cash items | 9.63M | 5.49M | 10.23M | 36.33M | 11.29M | |||
| OPERATING CASH FLOW | -25.58M | -6.38M | -9.79M | -32.98M | -45.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.02M | -995.00K | -2.52M | -910.00K | -520.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -1.02M | -995.00K | -2.52M | -910.00K | -520.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -12.38M | -22.49M | -2.03M | 0.00 | 25.25M | |||
| Stock Issued/Repurchased | 98.98M | 17.26M | 13.59M | 30.12M | 6.22M | |||
| Other Financing Activity | 8.32M | 9.20M | 0.00 | -10.00K | -3.01M | |||
| FINANCING CASH FLOW | 94.92M | 3.97M | 11.56M | 30.11M | 28.46M | |||
| CHANGE IN CASH | 68.32M | -3.40M | -750.00K | -3.78M | -17.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.58M | -6.38M | -9.79M | -32.98M | -45.46M | |||
| Capital Expenditure | -1.02M | -995.00K | -2.52M | -910.00K | -520.00K | |||
| FREE CASH FLOW | -26.61M | -7.38M | -12.31M | -33.89M | -45.98M | |||
All data in USD